HWM
ABBV icon

HighMark Wealth Management’s AbbVie ABBV Stock Holding History

HighMark Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1K Buy
64
+32
+100% +$6.88K 0.01% 268
2026
Q1 		$6.96K Hold
32
– – ﹤0.01% 335
2025
Q4 		$7.31K Hold
32
– – ﹤0.01% 355
2025
Q3 		$7.41K Sell
32
-17
-35% -$3.46K ﹤0.01% 345
2025
Q2 		$9.1K Sell
49
-4
-8% -$743 ﹤0.01% 325
2025
Q1 		$14.9K Sell
53
-22
-29% -$4.28K 0.01% 231
2024
Q4 		$13.3K Sell
75
-4
-5% -$735 0.01% 250
2024
Q3 		$15.6K Sell
79
-5
-6% -$933 0.01% 233
2024
Q2 		$14.4K Buy
84
+32
+62% +$5.3K 0.01% 231
2024
Q1 		$9.47K Buy
52
+22
+73% +$3.79K 0.01% 286
2023
Q4 		$4.65K Sell
30
-91
-75% -$13.3K ﹤0.01% 379
2023
Q3 		$18K Buy
121
+105
+656% +$15.4K 0.02% 191
2023
Q2 		$2.16K Hold
16
– – ﹤0.01% 448
2023
Q1 		$2.55K Hold
16
– – ﹤0.01% 479
2022
Q4 		$2.59K Sell
16
-37
-70% -$5.67K ﹤0.01% 407
2022
Q3 		$7K Buy
53
+3
+6% +$430 0.01% 282
2022
Q2 		$8K Sell
50
-3
-6% -$458 0.01% 270
2022
Q1 		$9K Hold
53
– – 0.01% 278
2021
Q4 		$7K Buy
53
+3
+6% +$354 ﹤0.01% 305
2021
Q3 		$5K Buy
50
+8
+19% +$914 ﹤0.01% 345
2021
Q2 		$5K Buy
42
+1
+2% +$113 ﹤0.01% 346
2021
Q1 		$4K Buy
+41
New +$4.38K ﹤0.01% 350
2020
Q4 		– Sell
-166
Closed -$15K – 441
2020
Q3 		$15K Buy
166
+2
+1% +$188 0.01% 185
2020
Q2 		$16K Buy
+164
New +$14.4K 0.02% 151
2020
Q1 		– Sell
-202
Closed -$17K – 351
2019
Q4 		$17K Buy
+202
New +$16.8K 0.02% 144

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HighMark Wealth Management's ABBV Position: Q2 2026 in Review

HighMark Wealth Management increased its AbbVie (ABBV) stake by 100% in Q2 2026, buying an estimated $6.88K and bringing the position to 64 shares worth $16.1K. The position accounts for 0.01% of the portfolio, ranked #268.

HighMark Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 25 quarters since. The position peaked at $18K in Q3 2023. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • HighMark Wealth Management held 64 shares of AbbVie worth $16.1K as of Q2 2026.
  • HighMark Wealth Management bought 32 AbbVie shares in Q2 2026, an estimated $6.88K.
  • AbbVie made up 0.01% of HighMark Wealth Management's portfolio in Q2 2026, its #268 holding.
  • HighMark Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 25 quarters since.
  • HighMark Wealth Management's AbbVie position peaked at $18K in Q3 2023.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.